-
1 week ago | 
agsjournals.onlinelibrary.wiley.com | Timothy Anderson |John Ayanian |Shoshana Herzig |Jeffrey Souza
Key points ○ In this longitudinal analysis of 94 million Medicare discharges, between 2010 and 2022, primary care follow-up after return to home increased from 51.5% to 57.5% for patients discharged directly home and from 24.3% to 28.4% for patients discharged to skilled nursing facilities (SNF) then home.
-
2 months ago | 
jamanetwork.com | Michael Incze |Timothy Anderson |William Becker |Karen H Seal
Integrating Buprenorphine Into Chronic Pain Treatment—Putting the Choice in VOICE Buprenorphine, Pain, and Opioid Use in Patients Taking High-Dose Long-Term Opioids William C. Becker, MD; Karen H. Seal, MD, MPH; David B. Nelson, PhD; Beth M. DeRonne, PharmD; Allyson M. Kats, MS; Benjamin J. Morasco, PhD; Joseph W. Frank, MD, MPH; Una E. Makris, MD, MSc; Jacob T. Painter, PharmD, MBA, PhD; Kelli D. Allen, PhD; Amanda S. Mixon, MD, MS, MSPH; Amy Bohnert, PhD; Thomas E.
-
Jan 28, 2025 | 
healio.com | Scott Buzby |Richard Smith |Timothy Anderson
Certain low-risk populations continue baby aspirin use, despite risk and clinical guidance• Some Asian, Black and Mexican American adults at low ASCVD risk continue taking baby aspirin, despite risk and clinical guidance. • Similar observations were reported for those on Medicaid or without insurance.
-
Nov 25, 2024 | 
jamanetwork.com | Lily G Bessette |Timothy Anderson
Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population Glucagon-like peptide 1 (GLP-1) receptor agonists liraglutide and semaglutide and dual GLP-1 and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonist tirzepatide are novel treatments for weight loss.
-
Sep 3, 2024 | 
jamanetwork.com | Timothy Anderson |Deborah Grady
Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle GLP-1 Receptor Agonist Use and Risk of Suicide Death Peter Ueda, MD, PhD; Jonas Söderling, PhD; Viktor Wintzell, PhD; Henrik Svanström, PhD; Laura Pazzagli, PhD; Björn Eliasson, MD, PhD; Mads Melbye, MD, DrMedSci; Anders Hviid, DrMedSci; Björn Pasternak, MD, PhD Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology Thomas A. Wadden,...
-
Aug 6, 2024 | 
healio.com | Scott Buzby |Richard Smith |Timothy Anderson
You've successfully added Practice Management in Cardiology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Follow-up care after CV events rose, but gaps remain for Black and Medicaid dual-eligible patients.
-
Jun 14, 2024 | 
healio.com | Erik Swain |Richard Smith |Timothy Anderson
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: In the new PREVENT heart disease risk calculator, fewer U.S. adults were eligible for primary prevention statin therapy vs. an older calculator. However, many people eligible for statins are not taking them.
-
May 30, 2024 | 
jamanetwork.com | Sonia Persaud |Samer Al Hadidi |Timothy Anderson |Grace Gallagher
Physicians commonly receive financial payments from industry, totaling $2.46 billion in 2022.1 These payments can represent scientific collaboration but may involve marketing efforts without scientific benefits, raising concerns regarding their influence on clinical decision-making.2
Pharmaceutical marketing frequently includes peer-to-peer promotion, often through speaking engagements.
-
May 28, 2024 | 
ahajournals.org | Adam P. Bress |Timothy Anderson |John Flack |Michael Hall
AbstractOver the past 3 decades, a substantial body of high-quality evidence has guided the diagnosis and management of elevated blood pressure (BP) in the outpatient setting. In contrast, there is a lack of comparable evidence for guiding the management of elevated BP in the acute care setting, resulting in significant practice variation.
-
Apr 12, 2024 | 
jamanetwork.com | Timothy Anderson |Edward R. Marcantonio |Robert W. Yeh |Jeffrey Souza
Key PointsQuestion
Has Medicare’s implementation of payments for transitional care management (TCM) services been associated with an increase in timely primary care follow-up after medical facility discharge?
